tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market
SNTI
Senti Biosciences
RESEARCH TOOLSreports
Want to see SNTI full AI Analyst Report?

Senti Biosciences (SNTI) Ratios

255 Followers

Senti Biosciences Ratios

SNTI's free cash flow for Q1 2026 was $1.00. For the 2026 fiscal year, SNTI's free cash flow was decreased by $ and operating cash flow was $-718.63. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.04 1.67 4.49 5.62 5.68
Quick Ratio
 1.04 1.67 4.49 5.62 5.68
Cash Ratio
 0.63 1.18 3.67 2.84 3.19
Solvency Ratio
 -1.34 -1.27 -0.65 -1.25 -1.01
Operating Cash Flow Ratio
 -2.58 -3.11 -3.15 -4.13 -1.93
Short-Term Operating Cash Flow Coverage
 -6.26 -8.15 0.00 0.00 0.00
Net Current Asset Value
$ -20.89M$ -22.36M$ -13.23M$ 18.63M$ 49.05M
Leverage Ratios
Debt-to-Assets Ratio
 0.50 0.56 0.34 0.32 0.21
Debt-to-Equity Ratio
 7.46 5.17 1.31 0.56 0.29
Debt-to-Capital Ratio
 0.88 0.84 0.57 0.36 0.23
Long-Term Debt-to-Capital Ratio
 0.84 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 14.91 9.16 3.81 1.79 1.42
Debt Service Coverage Ratio
 -9.00 -11.27 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.74 0.02 0.00 0.00 0.00
Interest Debt Per Share
 0.62 0.13 7.32 8.49 8.44
Net Debt to EBITDA
 -0.19 -0.21 0.27 -0.03 0.35
Profitability Margins
Gross Profit Margin
-6134.21%-16431.82%0.00%100.00%100.00%
EBIT Margin
-149376.32%-289668.18%0.00%-3375.38%-1889.35%
EBITDA Margin
-139550.00%-273136.36%0.00%-3100.91%-1770.05%
Operating Profit Margin
-154810.53%-289668.18%0.00%-4687.92%-1889.35%
Pretax Profit Margin
-135650.00%-279263.64%0.00%-4216.68%-1511.41%
Net Profit Margin
-135650.00%-279263.64%0.00%-3592.42%-1771.45%
Continuous Operations Profit Margin
-135650.00%-279263.64%0.00%-4216.68%-1511.41%
Net Income Per EBT
100.00%100.00%100.00%85.20%117.21%
EBT Per EBIT
87.62%96.41%86.49%89.95%80.00%
Return on Assets (ROA)
-134.80%-119.94%-53.95%-59.47%-32.20%
Return on Equity (ROE)
-503.79%-1099.27%-205.82%-106.19%-45.74%
Return on Capital Employed (ROCE)
-245.39%-171.08%-72.07%-86.81%-38.15%
Return on Invested Capital (ROIC)
-196.99%-149.67%-68.24%-83.58%-37.69%
Return on Tangible Assets
-134.80%-119.94%-53.95%-59.47%-32.20%
Earnings Yield
-168.64%-26.27%-327.24%-242.64%-93.94%
Efficiency Ratios
Receivables Turnover
 0.22 0.07 0.00 0.11 5.25
Payables Turnover
 0.00 1.24 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 <0.01 0.00 0.05 0.04
Asset Turnover
 <0.01 <0.01 0.00 0.02 0.02
Working Capital Turnover Ratio
 <0.01 <0.01 0.00 0.03 0.05
Cash Conversion Cycle
 1.65K 5.06K 0.00 3.27K 69.53
Days of Sales Outstanding
 1.65K 5.36K 0.00 3.27K 69.53
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 295.35 0.00 0.00 0.00
Operating Cycle
 1.65K 5.36K 0.00 3.27K 69.53
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.19 -0.19 -9.01 -11.81 -7.94
Free Cash Flow Per Share
 -1.20 -0.19 -9.01 -14.52 -17.35
CapEx Per Share
 <0.01 <0.01 <0.01 2.71 9.41
Free Cash Flow to Operating Cash Flow
 1.01 1.00 1.00 1.23 2.19
Dividend Paid and CapEx Coverage Ratio
 -188.14 -221.65 -1.59K -4.35 -0.84
Capital Expenditure Coverage Ratio
 -188.14 -221.65 -1.59K -4.35 -0.84
Operating Cash Flow Coverage Ratio
 -1.93 -1.50 -1.23 -1.39 -0.94
Operating Cash Flow to Sales Ratio
 -970.39 -1.97K 0.00 -26.49 -10.62
Free Cash Flow Yield
-142.88%-18.66%-256.78%-220.02%-123.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.59 -3.81 -0.31 -0.41 -1.06
Price-to-Sales (P/S) Ratio
 682.80 10.63K 0.00 14.81 18.86
Price-to-Book (P/B) Ratio
 11.92 41.84 0.63 0.44 0.49
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.70 -5.36 -0.39 -0.45 -0.81
Price-to-Operating Cash Flow Ratio
 -0.83 -5.38 -0.39 -0.56 -1.78
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.05 <0.01 >-0.01 -0.23
Price-to-Fair Value
 11.92 41.84 0.63 0.44 0.49
Enterprise Value Multiple
 -0.68 -4.10 -0.03 -0.51 -0.71
Enterprise Value
 36.15M 246.30M 1.50M 31.03M 41.44M
EV to EBITDA
 -0.68 -4.10 -0.03 -0.51 -0.71
EV to Sales
 951.38 11.20K 0.00 15.69 12.61
EV to Free Cash Flow
 -0.98 -5.64 -0.04 -0.48 -0.54
EV to Operating Cash Flow
 -0.98 -5.67 -0.04 -0.59 -1.19
Tangible Book Value Per Share
 0.08 0.02 5.58 15.08 28.96
Shareholders’ Equity Per Share
 0.08 0.02 5.58 15.08 28.96
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 0.00 0.45 0.75
Net Income Per Share
 -1.66 -0.27 -11.49 -16.01 -13.25
Tax Burden
 1.00 1.00 1.00 0.85 1.17
Interest Burden
 0.91 0.96 0.87 1.25 0.80
Research & Development to Revenue
 877.95 1.71K 0.00 16.25 8.57
SG&A to Revenue
 635.11 1.19K 0.00 17.63 11.45
Stock-Based Compensation to Revenue
 112.26 259.36 0.00 4.89 4.99
Income Quality
 0.72 0.71 0.78 0.74 0.60
Currency in USD